Christopher Austin, GSK SVP of research technologies

GSK ac­quires tiny RNA start­up Elsie, boost­ing its grand plans for de­vel­op­ing RNA drugs

GSK is boost­ing its RNA am­bi­tions, an­nounc­ing Thurs­day it has ac­quired a small, pri­vate­ly held San Diego start­up called Elsie Biotech­nolo­gies that the British drug­mak­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.